The antibody is a monoclonal antibody selectively targeting MUC1, a glycoprotein frequently upregulated in various cancers , including pancreatic adenocarcinoma . Its mechanism of action involves binding to MUC1, stimulating an cellular cytotoxic response that leads to cancerous cell destruction